Tag results:

pancreatic cancer

Drug-Dependent Morphological Transitions in Spherical and Worm-Like Polymeric Micelles Define Stability and Pharmacological Performance of Micellar Drugs

[Small] It was observed that poly(2-oxazoline)-based polymeric micelles could be elongated over time from a spherical structure to worm-like structure, with elongation influenced by several conditions, including the amount and type of drug loaded into the micelles.

IMB5036 Inhibits Human Pancreatic Cancer Growth Primarily through Activating Necroptosis

[Basic & Clinical Pharmacology & Toxicology] MLKL inhibitor NSA attenuated the killing effect of IMB5036 on pancreatic cancer cells. IMB5036 stimulated translocation of MLKL and p-MLKL from cytoplasm to cell membrane.

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Limitations and Prospects: A Systematic Review

[Cell Communication and Signaling] Pancreatic ductal adenocarcinoma is not sensitive to monotherapy with immune checkpoint inhibitors, which might be related to the inhibitory immune microenvironment of pancreatic cancer.

Neoadjuvant Therapy Alters the Collagen Architecture of Pancreatic Cancer Tissue via Ephrin-A5

[British Journal of Cancer] Researchers analyzed the alteration of collagen and gene expression profiles in pancreatic cancer tissues after NAT. Additionally, we examined the biological role of Ephrin-A5 using primary cultured cancer-associated fibroblasts (CAFs).

Glycosylation of MUC6 by α1,4-Linked N-acetylglucosamine Enhances Suppression of Pancreatic Cancer Malignancy

[Cancer Science] Investigators ectopically expressed α1,4-N-acetylglucosaminyltransferase (α4GnT), the α1,4-linked N-acetylglucosamine biosynthetic enzyme, together with MUC6 in the human pancreatic cancer cell lines MIA PaCa-2 and PANC-1, neither of which expressed α4GnT and MUC6.

Empirical Identification and Validation of Tumor-Targeting T Cell Receptors from Circulation Using Autologous Pancreatic Tumor Organoids

[Journal For Immunotherapy of Cancer] Autologous tumor organoids were stimulated with T cells from the patients’ peripheral blood for two weeks to generate the organoid-primed T cells.

Popular